Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law) - Image 1

£100.00

Edward Elgar Publishing Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Name: Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)
Brand: Edward Elgar Publishing
Price: 100.0 GBP
Availability: InStock

Law

This is the most expensive it has ever been. Walk away.

£100 today · previous high £100 · all-time low £74

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 121 days • 111 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 121 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £81 (68 days, 61.3%)

Price range: £74 - £100

Price levels: 5 different prices over 111 days

Description

This book comprehensively elaborates on the EU framework for regulatory protection in life science industries. Żaneta Zemła-Pacud discusses the rules governing regulatory exclusivities and rewards for both innovative life science products and the regulatory data underlying them. The analysis focuses primarily on pharmaceuticals, such as reference medicinal products, orphan drugs and paediatric medicines, but it also encompasses goods from the agrochemical and food sectors, such as plant protection products, novel food, genetically modified food and feed. The book illustrates how regulatory exclusivities and rewards are granted, what protection they confer, and how they can be enforced. Recognising their practical importance, it further presents how regulatory protection is integrated into IP strategies and what challenges this may pose. Against this background, the author presents and comments on coming changes to the system and provides an up-to-date analysis of the legislation driving EU reform of pharmaceutical regulation. To complete the picture of regulatory protection in the EU, the book situates the system within the framework of other protective regimes, including the protection of regulatory data against disclosure. Finally, referring to European civil law tradition, the author carefully analyses the framework’s normative legal bases and proposes categorising regulatory protection as a sui generis instrument of protection for Intellectual Property. This book is an insightful and stimulating contribution to the literature on intellectual property and pharmaceutical law. It is an essential read for scholars in those fields and policymakers involved in the legal reform of the pharmaceutical sector. Practising lawyers, judges, and national regulators will greatly benefit from timely insights into the field.

Product Specifications

Brand: Edward Elgar Publishing
Format: Hardcover
ASIN: 1035332272
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 20 June 2025
Listed Since: 15 December 2024

Barcode

No barcode data available

Edward Elgar Publishing Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Guide to EU Pharmaceutical Regulatory Law

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Guide to EU and UK Pharmaceutical Regulatory Law

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries (Routledge Research in Health Law)

Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Intellectual Property Law and Access to Medicines: TRIPS Agreement, Health, and Pharmaceuticals (Law, Development and Globalization)

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

Global Issues in Pharmaceutical Marketing

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, Second Edition

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

World Pharmaceutical Industry

Springer - Innovation and Marketing in Pharmaceutical Industry

The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics

Development and Evaluation of Drugs: From Laboratory through Licensure to Market